Healthcare provider profile · identity verified

Dana Brown

Physician Assistant · ALBUQUERQUE, NM · NPI 1508237371

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	291	78
Atorvastatin Calcium	Atorvastatin Calcium	214	62
Amlodipine Besylate	Amlodipine Besylate	206	60
Gabapentin	Gabapentin	194	41
Lisinopril	Lisinopril	166	53
Simvastatin	Simvastatin	135	38
Rosuvastatin Calcium	Rosuvastatin Calcium	112	31
Famotidine	Famotidine	105	24
Losartan Potassium	Losartan Potassium	95	29
Fluticasone Propionate	Fluticasone Propionate	90	38
Baclofen	Baclofen	89	19
Trazodone Hcl	Trazodone Hcl	83	26
Metformin Hcl	Metformin Hcl	81	24
Metoprolol Succinate	Metoprolol Succinate	80	26
Metformin Hcl Er	Metformin Hcl	78	26
Pravastatin Sodium	Pravastatin Sodium	74	17
Buspirone Hcl	Buspirone Hcl	73	21
Omeprazole	Omeprazole	71	18
Alendronate Sodium	Alendronate Sodium	60	16
Allopurinol	Allopurinol	60	suppressed
Mirtazapine	Mirtazapine	60	20
Albuterol Sulfate Hfa	Albuterol Sulfate	59	28
Pantoprazole Sodium	Pantoprazole Sodium	58	16
Pregabalin	Pregabalin	56	12
Trulicity	Dulaglutide	54	suppressed
Sertraline Hcl	Sertraline Hcl	52	15
Lovastatin	Lovastatin	50	14
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	11
Tamsulosin Hcl	Tamsulosin Hcl	49	16
Duloxetine Hcl	Duloxetine Hcl	46	13
Montelukast Sodium	Montelukast Sodium	46	13
Hydrochlorothiazide	Hydrochlorothiazide	42	16
Ventolin Hfa	Albuterol Sulfate	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	15
Potassium Chloride	Potassium Chloride	37	12
Tramadol Hcl	Tramadol Hcl	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Furosemide	Furosemide	33	11
Finasteride	Finasteride	31	suppressed
Carvedilol	Carvedilol	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	17
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Prednisone	Prednisone	25	21
Farxiga	Dapagliflozin Propanediol	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Nystatin	Nystatin	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Mounjaro	Tirzepatide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	16
Donepezil Hcl	Donepezil Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	11
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Nystop	Nystatin	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Glipizide Er	Glipizide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Eliquis	Apixaban	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error